AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,792,000 | – | 3,853,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 157,390,000 | $141,877,000 | 3.17% |
| Birch Grove Capital LP | 8,000,000 | $7,200,000 | 2.94% |
| PFM Health Sciences, LP | 48,150,000 | $43,919,000 | 1.64% |
| SILVERBACK ASSET MANAGEMENT LLC | 8,505,000 | $7,665,000 | 1.04% |
| DAFNA Capital Management LLC | 1,500,000 | $1,345,000 | 0.35% |
| DeepCurrents Investment Group LLC | 8,696,000 | $7,756,000 | 0.24% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,092,000 | $10,005,000 | 0.23% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,235,000 | $8,358,000 | 0.13% |
| Verition Fund Management LLC | 2,441,000 | $2,227,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $5,473,000 | 0.02% |